Tumor-bone cell interactions in bone metastases

Pierrick G J Fournier, Lauren K. Dunn, Gregory A. Clines, Theresa Guise

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The development of bone metastasis is an organized multi-step process in which some organs are preferential targets. In patients with advanced cancer, bone is the third most common site for metastases after lung and liver. Some cancers are particularly osteophilic, such as cancers of the breast and prostate where bone metastases occur in 60 to 70% of patients. Bone metastases occurrence can be explained by the expression of different malignant factors such as the chemokine receptors CXCR4 or CX3CR1, or the integrin αVβ3 promoting cancer cell homing to bone. Another critical parameter of tumor cell development in bone is their ability to survive and grow in the bone microenvironment. Cancer cells (the seeds) arriving in the bone marrow cavity will not grow if they are not properly responsive or adapted to the bone environment (the soil). Bone is a unique and rich environment whose integrity relies on the balance between osteoclastic bone resorption and osteoblastic bone formation to renew and adapt. The arrival of tumor cells and their interactions with bone cells disrupts normal bone remodeling causing abnormal new bone formation or bone destruction that characterizes osteoblastic and osteolytic metastases, respectively. Osteoblastic metastases are common with advanced prostate cancer while breast cancer bone metastases are typically osteolytic. However, many bone metastases are mixed and contain both osteoblastic and osteolytic characteristics. These skeletal complications have significant clinical consequences (hypercalcemia, intractable pain, fractures, nerve compression syndromes) that reduce the quality of life of these patients. More importantly, unbalanced bone remodeling provides metastatic tumor cells the means to grow and survive in bone.

Original languageEnglish (US)
Title of host publicationBone Cancer
PublisherElsevier Inc.
ISBN (Print)9780123748959
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Cell Communication
Neoplasm Metastasis
Bone and Bones
Neoplasms
Bone Neoplasms
Bone Remodeling
Bone Development
Breast Neoplasms
Osteogenesis
Prostatic Neoplasms
Nerve Compression Syndromes
Intractable Pain
Chemokine Receptors
Hypercalcemia
Bone Resorption
Integrins
Seeds
Soil
Bone Marrow
Quality of Life

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Cite this

Fournier, P. G. J., Dunn, L. K., Clines, G. A., & Guise, T. (2010). Tumor-bone cell interactions in bone metastases. In Bone Cancer Elsevier Inc.. https://doi.org/10.1016/B978-0-12-374895-9.00002-5

Tumor-bone cell interactions in bone metastases. / Fournier, Pierrick G J; Dunn, Lauren K.; Clines, Gregory A.; Guise, Theresa.

Bone Cancer. Elsevier Inc., 2010.

Research output: Chapter in Book/Report/Conference proceedingChapter

Fournier, PGJ, Dunn, LK, Clines, GA & Guise, T 2010, Tumor-bone cell interactions in bone metastases. in Bone Cancer. Elsevier Inc. https://doi.org/10.1016/B978-0-12-374895-9.00002-5
Fournier PGJ, Dunn LK, Clines GA, Guise T. Tumor-bone cell interactions in bone metastases. In Bone Cancer. Elsevier Inc. 2010 https://doi.org/10.1016/B978-0-12-374895-9.00002-5
Fournier, Pierrick G J ; Dunn, Lauren K. ; Clines, Gregory A. ; Guise, Theresa. / Tumor-bone cell interactions in bone metastases. Bone Cancer. Elsevier Inc., 2010.
@inbook{d791bdf9cb784db984471bec60bfb9bf,
title = "Tumor-bone cell interactions in bone metastases",
abstract = "The development of bone metastasis is an organized multi-step process in which some organs are preferential targets. In patients with advanced cancer, bone is the third most common site for metastases after lung and liver. Some cancers are particularly osteophilic, such as cancers of the breast and prostate where bone metastases occur in 60 to 70{\%} of patients. Bone metastases occurrence can be explained by the expression of different malignant factors such as the chemokine receptors CXCR4 or CX3CR1, or the integrin αVβ3 promoting cancer cell homing to bone. Another critical parameter of tumor cell development in bone is their ability to survive and grow in the bone microenvironment. Cancer cells (the seeds) arriving in the bone marrow cavity will not grow if they are not properly responsive or adapted to the bone environment (the soil). Bone is a unique and rich environment whose integrity relies on the balance between osteoclastic bone resorption and osteoblastic bone formation to renew and adapt. The arrival of tumor cells and their interactions with bone cells disrupts normal bone remodeling causing abnormal new bone formation or bone destruction that characterizes osteoblastic and osteolytic metastases, respectively. Osteoblastic metastases are common with advanced prostate cancer while breast cancer bone metastases are typically osteolytic. However, many bone metastases are mixed and contain both osteoblastic and osteolytic characteristics. These skeletal complications have significant clinical consequences (hypercalcemia, intractable pain, fractures, nerve compression syndromes) that reduce the quality of life of these patients. More importantly, unbalanced bone remodeling provides metastatic tumor cells the means to grow and survive in bone.",
author = "Fournier, {Pierrick G J} and Dunn, {Lauren K.} and Clines, {Gregory A.} and Theresa Guise",
year = "2010",
doi = "10.1016/B978-0-12-374895-9.00002-5",
language = "English (US)",
isbn = "9780123748959",
booktitle = "Bone Cancer",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Tumor-bone cell interactions in bone metastases

AU - Fournier, Pierrick G J

AU - Dunn, Lauren K.

AU - Clines, Gregory A.

AU - Guise, Theresa

PY - 2010

Y1 - 2010

N2 - The development of bone metastasis is an organized multi-step process in which some organs are preferential targets. In patients with advanced cancer, bone is the third most common site for metastases after lung and liver. Some cancers are particularly osteophilic, such as cancers of the breast and prostate where bone metastases occur in 60 to 70% of patients. Bone metastases occurrence can be explained by the expression of different malignant factors such as the chemokine receptors CXCR4 or CX3CR1, or the integrin αVβ3 promoting cancer cell homing to bone. Another critical parameter of tumor cell development in bone is their ability to survive and grow in the bone microenvironment. Cancer cells (the seeds) arriving in the bone marrow cavity will not grow if they are not properly responsive or adapted to the bone environment (the soil). Bone is a unique and rich environment whose integrity relies on the balance between osteoclastic bone resorption and osteoblastic bone formation to renew and adapt. The arrival of tumor cells and their interactions with bone cells disrupts normal bone remodeling causing abnormal new bone formation or bone destruction that characterizes osteoblastic and osteolytic metastases, respectively. Osteoblastic metastases are common with advanced prostate cancer while breast cancer bone metastases are typically osteolytic. However, many bone metastases are mixed and contain both osteoblastic and osteolytic characteristics. These skeletal complications have significant clinical consequences (hypercalcemia, intractable pain, fractures, nerve compression syndromes) that reduce the quality of life of these patients. More importantly, unbalanced bone remodeling provides metastatic tumor cells the means to grow and survive in bone.

AB - The development of bone metastasis is an organized multi-step process in which some organs are preferential targets. In patients with advanced cancer, bone is the third most common site for metastases after lung and liver. Some cancers are particularly osteophilic, such as cancers of the breast and prostate where bone metastases occur in 60 to 70% of patients. Bone metastases occurrence can be explained by the expression of different malignant factors such as the chemokine receptors CXCR4 or CX3CR1, or the integrin αVβ3 promoting cancer cell homing to bone. Another critical parameter of tumor cell development in bone is their ability to survive and grow in the bone microenvironment. Cancer cells (the seeds) arriving in the bone marrow cavity will not grow if they are not properly responsive or adapted to the bone environment (the soil). Bone is a unique and rich environment whose integrity relies on the balance between osteoclastic bone resorption and osteoblastic bone formation to renew and adapt. The arrival of tumor cells and their interactions with bone cells disrupts normal bone remodeling causing abnormal new bone formation or bone destruction that characterizes osteoblastic and osteolytic metastases, respectively. Osteoblastic metastases are common with advanced prostate cancer while breast cancer bone metastases are typically osteolytic. However, many bone metastases are mixed and contain both osteoblastic and osteolytic characteristics. These skeletal complications have significant clinical consequences (hypercalcemia, intractable pain, fractures, nerve compression syndromes) that reduce the quality of life of these patients. More importantly, unbalanced bone remodeling provides metastatic tumor cells the means to grow and survive in bone.

UR - http://www.scopus.com/inward/record.url?scp=84882825955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882825955&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374895-9.00002-5

DO - 10.1016/B978-0-12-374895-9.00002-5

M3 - Chapter

SN - 9780123748959

BT - Bone Cancer

PB - Elsevier Inc.

ER -